8-K: Bausch Health Shareholders Elect Directors and Approve Executive Compensation at 2025 Annual Meeting

Bausch Health held its Annual Meeting of Shareholders on May 13, 2025, where shareholders elected directors, approved executive compensation, and ratified the employee stock purchase plan and auditor appointment.

Summary

• Bausch Health Companies Inc. held its Annual Meeting of Shareholders on May 13, 2025.
• Shareholders elected eleven directors to the Board, each serving until the 2026 Annual Meeting.
• The elected directors include Thomas J. Appio, Christian A. Garcia, Brett M. Icahn, Sarah B. Kavanagh, Frank D. Lee, Steven D. Miller, Richard C. Mulligan, John A. Paulson, Robert N. Power, and Amy B. Wechsler.
• An advisory vote approved the compensation of the company's Named Executive Officers.
• The Bausch Health Companies Inc. 2025 Employee Stock Purchase Plan was approved.
• PricewaterhouseCoopers LLP was appointed as the company's independent registered public accounting firm until the 2026 Annual Meeting.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures, indicating stability and alignment between management and shareholders. The sentiment is neutral to positive.

Positives

• Shareholder approval of all proposals indicates strong support for the company's direction.
• The election of directors ensures continuity and stability in leadership.
• Approval of the Employee Stock Purchase Plan can boost employee morale and align their interests with shareholders.

Future Outlook

The newly elected directors will serve until the 2026 Annual Meeting, and PricewaterhouseCoopers LLP will act as the auditor until then.

Industry Context

Annual shareholder meetings are a standard part of corporate governance, allowing shareholders to vote on key issues and hold management accountable.

Stakeholder Impact

• Shareholders have exercised their voting rights on key company matters.
• Employees may benefit from the approved Employee Stock Purchase Plan.

Next Steps

• The elected directors will continue to serve on the Board.
• The company will implement the approved Employee Stock Purchase Plan.
• PricewaterhouseCoopers LLP will continue as the independent auditor.

Key Dates

Keywords

Annual Meeting, Shareholders, Board of Directors, Executive Compensation, Employee Stock Purchase Plan, Auditor, PricewaterhouseCoopers, Bausch Health